RGC
Regencell Bioscience Holdings Ltd
NASDAQ: RGC · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$28.95
-0.34% today
Updated 2026-04-29
Market cap
$14.32B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.01
Dividend yield
—
52W range
$2 – $84
Volume
0.1M
Regencell Bioscience Holdings Ltd (RGC) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.52B | $2.60B | $2.66B | $2.77B | $2.89B | $2.81B | $2.68B | $2.82B | $3.04B | $2.99B | $3.13B | $3.20B | $3.16B | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Revenue growth (YoY) | — | +3.3% | +2.4% | +4.1% | +4.4% | -3.0% | -4.5% | +5.3% | +7.6% | -1.6% | +4.6% | +2.2% | -1.1% | -100.0% | — | — | — | — | — | — |
| Cost of revenue | $96.00M | $104.00M | $103.00M | $106.00M | $1.16B | $101.00M | $96.00M | $101.00M | $111.00M | $111.00M | $1.21B | $1.23B | $123.00M | — | $9516.00 | $26456.00 | $604397.00 | $769687.00 | $745588.00 | $392743.00 |
| Gross profit | $2.42B | $2.49B | $2.56B | $2.67B | $1.74B | $2.71B | $2.59B | $2.72B | $2.93B | $2.88B | $1.92B | $1.97B | $3.04B | — | $-9516.00 | $-26456.00 | $-604397.00 | $-769687.00 | $-745588.00 | $-392743.00 |
| Gross margin | 96.2% | 96.0% | 96.1% | 96.2% | 60.0% | 96.4% | 96.4% | 96.4% | 96.3% | 96.3% | 61.4% | 61.6% | 96.1% | — | — | — | — | — | — | — |
| R&D | — | — | — | — | — | — | — | — | — | — | — | — | — | $228223.00 | $386230.00 | $438323.00 | $2.51M | $1.58M | $1.07M | $948289.00 |
| SG&A | $61.00M | $65.00M | $63.00M | $62.00M | $443.00M | $66.70M | $65.80M | $68.80M | $73.70M | $74.40M | $500.30M | $512.20M | $86.60M | $159129.00 | $311934.00 | $941463.00 | $5.08M | $4.43M | $3.22M | — |
| Operating income | $269.00M | $308.00M | $322.00M | $284.00M | $313.40M | $215.80M | $221.30M | $334.20M | $339.80M | $306.40M | $339.00M | $344.20M | $271.70M | $-390990.00 | $-812371.00 | $-1.38M | $-7.62M | $-6.27M | $-4.74M | $-3.77M |
| Operating margin | 10.7% | 11.9% | 12.1% | 10.2% | 10.8% | 7.7% | 8.3% | 11.8% | 11.2% | 10.2% | 10.8% | 10.8% | 8.6% | — | — | — | — | — | — | — |
| EBITDA | $233.00M | $215.00M | $676.00M | $200.00M | $512.10M | $352.50M | $259.70M | $422.20M | $469.20M | $391.00M | $470.30M | $512.30M | $468.70M | $-390990.00 | $-802855.00 | $-1.35M | $-6.99M | $-5.29M | $-3.62M | $-3.19M |
| EBITDA margin | 9.3% | 8.3% | 25.4% | 7.2% | 17.7% | 12.6% | 9.7% | 14.9% | 15.4% | 13.1% | 15.0% | 16.0% | 14.8% | — | — | — | — | — | — | — |
| EBIT | $34.00M | $18.00M | $493.00M | $-2.00M | $310.20M | $126.30M | $58.00M | $236.00M | $264.70M | $179.00M | $253.50M | $281.60M | $213.90M | $-390990.00 | $-812371.00 | $-1.38M | $-7.59M | $-6.06M | $-4.36M | $-3.58M |
| Interest expense | $117.00M | $125.00M | $112.00M | $124.00M | $152.80M | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $23215.00 | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $91.00M | $86.00M | $363.00M | $72.00M | $95.50M | $77.60M | $40.30M | $144.80M | $157.70M | $105.60M | $153.40M | $170.40M | $112.30M | $-390990.00 | $-812371.00 | $-1.35M | $-7.42M | $-5.87M | $-4.30M | $-3.58M |
| Net income growth (YoY) | — | -5.5% | +322.1% | -80.2% | +32.6% | -18.7% | -48.1% | +259.3% | +8.9% | -33.0% | +45.3% | +11.1% | -34.1% | -100.3% | -107.8% | -65.8% | -451.2% | +20.9% | +26.7% | +16.7% |
| Profit margin | 3.6% | 3.3% | 13.6% | 2.6% | 3.3% | 2.8% | 1.5% | 5.1% | 5.2% | 3.5% | 4.9% | 5.3% | 3.6% | — | — | — | — | — | — | — |